CONGIU, CENZO
 Distribuzione geografica
Continente #
EU - Europa 142.515
NA - Nord America 9.231
AS - Asia 3.768
SA - Sud America 551
Continente sconosciuto - Info sul continente non disponibili 331
AF - Africa 126
OC - Oceania 8
Totale 156.530
Nazione #
IT - Italia 133.281
US - Stati Uniti d'America 9.107
NL - Olanda 6.666
CN - Cina 1.439
SG - Singapore 1.407
UA - Ucraina 910
BR - Brasile 447
FI - Finlandia 402
SE - Svezia 353
DE - Germania 331
VN - Vietnam 287
GB - Regno Unito 217
FR - Francia 208
HK - Hong Kong 130
IN - India 112
KR - Corea 101
CA - Canada 70
BD - Bangladesh 54
MA - Marocco 45
RU - Federazione Russa 41
AR - Argentina 38
MX - Messico 29
JP - Giappone 28
EG - Egitto 26
IQ - Iraq 25
PK - Pakistan 24
ES - Italia 21
EC - Ecuador 20
TR - Turchia 20
ID - Indonesia 18
ZA - Sudafrica 18
BE - Belgio 17
VE - Venezuela 16
AT - Austria 13
CO - Colombia 12
IR - Iran 12
SA - Arabia Saudita 12
JO - Giordania 11
TN - Tunisia 11
UZ - Uzbekistan 10
MY - Malesia 9
PT - Portogallo 9
TW - Taiwan 9
AZ - Azerbaigian 8
JM - Giamaica 8
PH - Filippine 8
TH - Thailandia 8
CL - Cile 7
IE - Irlanda 7
IL - Israele 7
OM - Oman 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
EU - Europa 6
HU - Ungheria 6
KE - Kenya 6
PE - Perù 6
NP - Nepal 5
DZ - Algeria 4
LT - Lituania 4
NG - Nigeria 4
RS - Serbia 4
DK - Danimarca 3
KZ - Kazakistan 3
RO - Romania 3
UY - Uruguay 3
CI - Costa d'Avorio 2
GA - Gabon 2
LB - Libano 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
RE - Reunion 1
Totale 156.203
Città #
Cagliari 130.309
Amsterdam 6.650
Uta 2.489
Woodbridge 893
Fairfield 742
Ashburn 670
Singapore 611
Chandler 539
Houston 536
Jacksonville 520
San Jose 439
Wilmington 432
Ann Arbor 416
Dallas 406
Boardman 394
Seattle 302
Cambridge 282
Helsinki 252
Nyköping 247
Beijing 221
Dearborn 154
Council Bluffs 153
Nanjing 148
Boston 125
Los Angeles 125
Hefei 120
Lauterbourg 115
Santa Clara 113
Hong Kong 103
Ho Chi Minh City 94
Munich 90
The Dalles 89
Seoul 84
New York 75
Shanghai 74
Buffalo 69
Nanchang 62
Milan 58
Hanoi 55
Shenyang 53
Hebei 46
San Diego 44
Guangzhou 40
Verona 40
Jiaxing 39
Tianjin 37
Toronto 37
São Paulo 36
Changsha 34
Redwood City 34
Dong Ket 32
Casablanca 31
Mountain View 29
Redondo Beach 29
Atlanta 25
Auburn Hills 23
Norwalk 23
Olbia 23
Washington 22
Chicago 21
Orange 21
Frankfurt am Main 19
Phoenix 19
Tokyo 19
Zhengzhou 19
Brooklyn 18
Jinan 17
London 17
Turku 16
Chennai 15
Columbus 15
Selargius 15
Belo Horizonte 14
Ferrara 14
Hangzhou 14
Rome 14
Sassari 14
Falls Church 13
Brussels 12
Cairo 12
Da Nang 12
San Francisco 12
Dhaka 11
Manchester 11
Ningbo 11
Nuremberg 11
Orem 11
Quito 11
Wuhan 11
Amman 10
Haiphong 10
Naples 10
Perugia 10
Rio de Janeiro 10
Kunming 9
Springfield 9
Baghdad 8
Brasília 8
Chapel Hill 8
Denver 8
Totale 150.472
Nome #
Synthesis and antiproliferative activity of 2,6-Dibenzylamino-3,5-dicyanopyridines on human cancer cell lines 12.504
Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents 6.609
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen 4.905
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.611
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.869
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.738
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.717
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.673
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.605
Interaction of the N-(3-Methylpyridin-2-yl)amide derivatives of flurbiprofen and ibuprofen with FAAH: Enantiomeric selectivity and binding mode 2.546
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.532
Critical role for prokineticin 2 in CNS autoimmunity 2.469
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.371
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide 2.357
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor 2.356
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.252
Synthesis and evaluation of new pyrazole-based carboxamides as modulators of the TrPv1 channel 2.218
New bis(pyridyl)methane derivatives from 4-hydroxy-2-pyridones: synthesis and antitumoral activity 2.211
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 2.131
Investigation of the mechanism of FAAH inhibition of profen amide derivatives 2.126
Simple synthesis of polyfunctional nitropyridines 2.088
A new and efficient synthesis of phthalazin-1(2H)-ones 2.071
Synthesis of triflouromethylated pyridinecarbonitriles 2.058
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.053
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 2.011
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.979
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.910
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.847
An important role for prokineticin 2 in autoimmune CNS demyelination 1.821
PPAR controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development 1.812
Synthesis and antitumor evaluation of 6-thioxo-, 6-oxo- and 2,4-dioxopyrimidine derivatives 1.809
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.794
null 1.768
Reaction of enaminonitriles with isocyanates. Synthesis of new 2-oxo- and 6-oxopyrimidines 1.760
null 1.650
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.470
DESIGN, SYNTHESIS, AND EVALUATION OF (ISO)NIPECOTAMIDE AND PIPERAZINYLUREA DERIVATIVES AS TRPV1 MODULATORS 1.383
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.352
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.281
New trifluoromethylated pyridines from functionalized N-1-acylacetamidrazones 1.258
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.245
null 1.242
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.167
Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties 1.097
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 912
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 846
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 834
null 825
Reactivity of N1-Acylacetamidrazones towards Diethyl Acetylenedicarboxylate: Cyclization to Ethyl Pyrroleacetates and 1-Acylaminopyridones 824
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 811
Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives 752
Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives 731
null 731
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors 724
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 717
Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines 713
null 670
Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents 661
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF DUAL FAAH – COX INHIBITORS 630
Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues 619
Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6- trifluoromethyl-3-pyridinecarboxylic acids 616
null 613
Synthesis and structural studies of 3-acylamino-4-amino-2,3-dihydro-2-iminothiazole-5-carboxylates and 4-acylhydrazino-2-aminothiazole-5-carboxylates 570
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 568
Synthesis and antimicrobial activity of some pyrrole derivatives 522
Synthesis and antimicrobial activity of some 1-arylideneamino-2-mercaptoimidazole derivatives 499
null 466
null 457
Synthesis and antimicrobial activity of some pyrrole derivatives. III. 2-(4-arylpiperazino)-3-ethoxycarbonyl-5-aryl-pyrrole derivatives. 452
Synthesis and antimicrobial activity of some pyrrole derivatives. IV. 2-arylidenhydrazino-3-ethoxycarbonyl (or cyano) pyrrole derivatives. 446
Synthesis and in vitro antitumoral activity of new N-phenyl-3-pyrrolecarbothioamides 437
Design, synthesis and pharmacological investigation on new FAAH inhibitors 428
null 424
Attività antimicrobica di derivati pirrolici 424
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF NEW FAAH INHIBITORS 418
null 416
null 414
PROGETTAZIONE, SINTESI, STUDI SAR E VALUTAZIONE BIOLOGICA DI NUOVIINIBITORI DELL’ENZIMA FAAH 408
Synthesis and structure of heterocyclic compounds, 1-amino-2,4-disubstituted imidazoles. 393
Synergistic activity between rifamycins and a new class of isothiosemicarbazones against Mycobacterium avium 388
Synthesis of 1-acyl-5-pyrazolones and pyrrolidino [2,3-c]pyrazol-3-ones 388
Design, Synthesis, Biological Activity and SAR of New FAAH Inhibitors 386
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifampicina e rifabutina nei confronti di Mycobacterium avium 383
Synthesis of 6-amino and 6-ethoxy-2(1H)-pyridone derivatives. 380
Synthesis and antifungal activities of N-arylideneaminoimidazole derivatives. 380
null 378
Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives 374
DERIVATI DIARILETEROCICLICI COME POTENZIALI AGENTI ANTITUMORALI 371
null 361
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis 358
Synthesis and antimycobacterial activity of new S-alkylisotiosemicarbazone derivatives 357
Attività Antimicobatterica di Nuovi S-alchilisotiosemicarbazoni e Potenziamento dell’Attività di Rifampicina e Rifabutina nei Confronti di M. Avium 353
null 350
Synthesis and Antitubercular activity of N1-Isonicotinoylamidrazones Derivatives 344
null 341
null 341
Concentrazioni sub-inibenti di isonicotinoilidrazoni potenziano l'attività di rifampicina e etambutolo nei confronti di Mycobacterium tuberculosis 340
Synergistic Activity between Rifamycins and a New Class of Isothiosemicarbazones against Mycobacterium avium 340
Synthesis of pyridines by heterocyclization of new dienamino esters. 333
null 332
Totale 136.275
Categoria #
all - tutte 205.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.790 0 345 336 236 225 315 313 293 281 470 353 623
2022/20237.334 730 726 657 519 535 908 490 1.070 467 345 575 312
2023/20249.379 422 365 449 713 975 1.628 1.563 546 446 645 743 884
2024/202555.285 20.762 13.225 13.053 2.052 1.635 1.129 1.205 155 327 1.260 194 288
2025/202611.723 299 410 844 747 289 352 950 577 5.939 820 393 103
2026/2027357 172 185 0 0 0 0 0 0 0 0 0 0
Totale 156.530